CJC-1295 vs DSIP
A comprehensive, data-driven comparison of CJC-1295 (Modified GRF 1-29) and DSIP (Delta Sleep-Inducing Peptide). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | CJC-1295 Modified GRF 1-29, DAC:GRF | DSIP Delta Sleep-Inducing Peptide |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Category 2 |
| Category | Growth Hormone | Sleep |
| Primary Use | Growth hormone optimization and anti-aging | Sleep disorders and stress reduction |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 1-2mg twice weekly (with DAC) | 100-300mcg before bed |
| Frequency | Twice weekly | Daily |
| Mechanism | Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce more growth hormone | Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1CJC-1295 is dosed twice weekly, while DSIP is daily.
- 2They belong to different categories: CJC-1295 (Growth Hormone) vs DSIP (Sleep).
Which Is Better For...
CJC-1295
More convenient dosing schedule (twice weekly)
DSIP
Fewer commonly reported side effects
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| CJC-1295 | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
| DSIP | $35 - $70/mo | Category 2 | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
CJC-1295 works via Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce. DSIP works via Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms. They differ in FDA approval status, efficacy data, and cost.
CJC-1295 typically costs $35 - $70/mo, while DSIP costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
CJC-1295 is not FDA-approved (Category 2 (pending reclassification)). DSIP is not FDA-approved (Category 2). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of CJC-1295 include Injection site reactions, Water retention, Numbness or tingling. Common side effects of DSIP include Injection site reactions, Drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two forms: with DAC (Drug Affinity Complex) for ex...
View Full CJC-1295 GuideDSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first discovered in 1977 in the brains of sleeping rabbits. Research suggests it may have broader effects on stress response, pain modulation, and...
View Full DSIP GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between CJC-1295 and DSIP should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.